Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether no monitoring changes mortality (at the end of compared with frequent monitoring (12 hours or less) of gastric residual volume (very low certainty).
1 finding from 1 review
Pneumonia · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether no monitoring changes pneumonia (until discontinued or up to 28 days) compared with frequent monitoring (12 hours or less) of gastric residual volume (very low certainty).
1 finding from 1 review
Length of hospital stay · adults receiving EN via nasogastric or gastrostomy tube
1 finding from 1 review
Disease activity · people with inflammatory bowel disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Flare‐ups or relapse (continuous) · people with inflammatory bowel disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life (adults) · people with inflammatory bowel disease
1 finding from 1 review
Disease activity · people with inflammatory bowel disease
1 finding from 1 review
Flare‐ups/relapse (dichotomous; adults) · people with inflammatory bowel disease
It is very uncertain whether telephone‐based disease monitoring changes flare‐ups/relapse (dichotomous; adults) compared with face‐to‐face monitoring (very low certainty).
1 finding from 1 review
Flare‐ups/relapse (dichotomous; children) · people with inflammatory bowel disease
It is very uncertain whether telephone‐based disease monitoring changes flare‐ups/relapse (dichotomous; children) compared with face‐to‐face monitoring (very low certainty).
1 finding from 1 review
Quality of life (adults) · people with inflammatory bowel disease
1 finding from 1 review
Quality of life (children) · people with inflammatory bowel disease
1 finding from 1 review
Disease activity · people with inflammatory bowel disease
1 finding from 1 review
Flare‐ups/relapse (dichotomous; adults) · people with inflammatory bowel disease
1 finding from 1 review
Quality of life (adults) · people with inflammatory bowel disease
1 finding from 1 review
Flare‐ups/relapse (dichotomous; adults) · people with inflammatory bowel disease
Web‐based disease monitoring showed no clear difference in flare‐ups/relapse (dichotomous; adults) compared with usual care (moderate certainty).
1 finding from 1 review
Flare‐ups or relapse (continuous) · people with inflammatory bowel disease
1 finding from 1 review
Flare‐ups/relapse (dichotomous; children) · people with inflammatory bowel disease
Web‐based disease monitoring showed no clear difference in flare‐ups/relapse (dichotomous; children) compared with usual care (low certainty).
1 finding from 1 review
Quality of life (adults) · people with inflammatory bowel disease
1 finding from 1 review
Disease activity · people with inflammatory bowel disease
1 finding from 1 review
Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether more frequent (less than eight hours) changes mortality (at the end of compared with less frequent (eight hours or greater) monitoring of gastric… (very low certainty).
1 finding from 1 review